50-State Survey of Telehealth Insurance Laws
Access Evolution: Post-Public Health Emergency Advances in Telehealth Laws Make Seeking Medical Care Easier for Many
May 6, 2024
Patients and health care professionals have been quick to adopt telemedicine and digital health technologies. In the last five years, the legal landscape for telehealth insurance coverage and reimbursement has expanded in several ways:
- More organizations are implementing and expanding robust virtual care programs to supplement their traditional in-person offerings.
- In rural areas, phone coverage helps those with limited access to broadband internet and in-person care.
- With telehealth and digital health resources, patients also get a boost in mental health care because these tools help address the imbalance in supply and demand.
- More states changed their laws to prohibiting exclusive telehealth platform arrangements, increasing competition among software companies and allowing individual clinics and hospitals to make decisions based on what works for them and their patients.
- There has been progress with payment parity — reimbursing providers at the same rate for telehealth as in-person, but there is still a way to go.
All of this together is steady progress, and it codifies by law improvements that patients have loved. Unfortunately, the market cannot rely on the health care industry to make these changes voluntarily — the laws passed by individual states serve as the bridge to solidify telehealth-based services as a core health insurance benefit for the patients who use them.
State Telehealth Insurance Laws 2019 vs. 2024
Author(s)
Related Insights
December 2, 2025
Health Care Law Today
Digital Health Technologies Use in Clinical Trials: Support from MAHA and Defined Expectations from FDA’s Final Guidance
Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America…
November 11, 2025
Health Care Law Today
M&A In GLP-1 Technology: Practical Recommendations And Best Practices
This article originally appeared on Pharmaceutical Online in November 2025. The GLP-1 revolution has rewritten the playbook for metabolic…
November 10, 2025
Health Care Law Today
FDA Considers Drug Pricing: Leadership Cites Consumer Cost as a Driver for Changes to Biosimilar Recommendations
“By streamlining the biosimilar development process and helping advance interchangeability, we can achieve massive cost reductions for…